Revolution Medicines (RVMD) Change in Account Payables (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Change in Account Payables of $16.9 million for Q1 2026, up 303.83% year-over-year from $4.2 million in Q1 2025, and up 260.53% quarter-over-quarter from -$10.5 million in Q4 2025.
Revolution Medicines (RVMD) Change in Account Payables (2019 - 2026) Analysis & Trends
Revolution Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $16.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 303.83% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $34.7 million (up 143.67% YoY), while the FY2025 annual figure was $9.5 million, up 247.49% from the prior year.
- Change in Account Payables for Q1 2026 stood at $16.9 million, up from -$10.5 million in the prior quarter.
- The five-year high for Change in Account Payables was $29.4 million in Q4 2024, with the low at -$29.0 million in Q1 2024.
- The 5-year median for Change in Account Payables is -$492000.0 (2022), against an average of $3.5 million.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 5317.46% in 2022, then tumbled 2658.1% in 2024.
- Revolution Medicines' Change in Account Payables stood at -$1.5 million in 2022, then surged by 1712.81% to $24.3 million in 2023, then climbed by 20.81% to $29.4 million in 2024, then slumped by 135.76% to -$10.5 million in 2025, then soared by 260.53% to $16.9 million in 2026.
- Business Quant data shows RVMD's Change in Account Payables at $16.9 million in Q1 2026, -$10.5 million in Q4 2025, and $19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | -10.50 Mn |
| Dec 31, 2025 | -10.50 Mn |
| Sep 30, 2025 | 19.55 Mn |
| Sep 30, 2025 | 19.55 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | -8.27 Mn |
| Mar 31, 2025 | -8.27 Mn |
| Dec 31, 2024 | 29.36 Mn |
| Dec 31, 2024 | 29.36 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Mar 31, 2024 | -28.96 Mn |
| Mar 31, 2024 | -28.96 Mn |